These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 29723062)

  • 1. Resolvin E1 attenuates injury-induced vascular neointimal formation by inhibition of inflammatory responses and vascular smooth muscle cell migration.
    Liu G; Gong Y; Zhang R; Piao L; Li X; Liu Q; Yan S; Shen Y; Guo S; Zhu M; Yin H; Funk CD; Zhang J; Yu Y
    FASEB J; 2018 Oct; 32(10):5413-5425. PubMed ID: 29723062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Serum HMGB2 Levels With In-Stent Restenosis: HMGB2 Promotes Neointimal Hyperplasia in Mice With Femoral Artery Injury and Proliferation and Migration of VSMCs.
    He YH; Wang XQ; Zhang J; Liu ZH; Pan WQ; Shen Y; Zhu ZB; Wang LJ; Yan XX; Yang K; Zhang RY; Shen WF; Ding FH; Lu L
    Arterioscler Thromb Vasc Biol; 2017 Apr; 37(4):717-729. PubMed ID: 28183701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel role of copper transport protein antioxidant-1 in neointimal formation after vascular injury.
    Kohno T; Urao N; Ashino T; Sudhahar V; McKinney RD; Hamakubo T; Iwanari H; Ushio-Fukai M; Fukai T
    Arterioscler Thromb Vasc Biol; 2013 Apr; 33(4):805-13. PubMed ID: 23349186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perivascular delivery of resolvin D1 inhibits neointimal hyperplasia in a rat model of arterial injury.
    Wu B; Mottola G; Chatterjee A; Lance KD; Chen M; Siguenza IO; Desai TA; Conte MS
    J Vasc Surg; 2017 Jan; 65(1):207-217.e3. PubMed ID: 27034112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic delivery of proresolving lipid mediators resolvin D2 and maresin 1 attenuates intimal hyperplasia in mice.
    Akagi D; Chen M; Toy R; Chatterjee A; Conte MS
    FASEB J; 2015 Jun; 29(6):2504-13. PubMed ID: 25777995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epac1 Deficiency Attenuated Vascular Smooth Muscle Cell Migration and Neointimal Formation.
    Kato Y; Yokoyama U; Yanai C; Ishige R; Kurotaki D; Umemura M; Fujita T; Kubota T; Okumura S; Sata M; Tamura T; Ishikawa Y
    Arterioscler Thromb Vasc Biol; 2015 Dec; 35(12):2617-25. PubMed ID: 26427796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Redox-sensitive transcription factor Nrf2 regulates vascular smooth muscle cell migration and neointimal hyperplasia.
    Ashino T; Yamamoto M; Yoshida T; Numazawa S
    Arterioscler Thromb Vasc Biol; 2013 Apr; 33(4):760-8. PubMed ID: 23413426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. D-series resolvin attenuates vascular smooth muscle cell activation and neointimal hyperplasia following vascular injury.
    Miyahara T; Runge S; Chatterjee A; Chen M; Mottola G; Fitzgerald JM; Serhan CN; Conte MS
    FASEB J; 2013 Jun; 27(6):2220-32. PubMed ID: 23407709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mineralocorticoid Receptor Deficiency in Macrophages Inhibits Neointimal Hyperplasia and Suppresses Macrophage Inflammation Through SGK1-AP1/NF-κB Pathways.
    Sun JY; Li C; Shen ZX; Zhang WC; Ai TJ; Du LJ; Zhang YY; Yao GF; Liu Y; Sun S; Naray-Fejes-Toth A; Fejes-Toth G; Peng Y; Chen M; Liu X; Tao J; Zhou B; Yu Y; Guo F; Du J; Duan SZ
    Arterioscler Thromb Vasc Biol; 2016 May; 36(5):874-85. PubMed ID: 26966277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MFAP4 Promotes Vascular Smooth Muscle Migration, Proliferation and Accelerates Neointima Formation.
    Schlosser A; Pilecki B; Hemstra LE; Kejling K; Kristmannsdottir GB; Wulf-Johansson H; Moeller JB; Füchtbauer EM; Nielsen O; Kirketerp-Møller K; Dubey LK; Hansen PB; Stubbe J; Wrede C; Hegermann J; Ochs M; Rathkolb B; Schrewe A; Bekeredjian R; Wolf E; Gailus-Durner V; Fuchs H; Hrabě de Angelis M; Lindholt JS; Holmskov U; Sorensen GL
    Arterioscler Thromb Vasc Biol; 2016 Jan; 36(1):122-33. PubMed ID: 26564819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulator of G-Protein Signaling 5 Prevents Smooth Muscle Cell Proliferation and Attenuates Neointima Formation.
    Daniel JM; Prock A; Dutzmann J; Sonnenschein K; Thum T; Bauersachs J; Sedding DG
    Arterioscler Thromb Vasc Biol; 2016 Feb; 36(2):317-27. PubMed ID: 26663397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 2,3,7,8-Tetrachlorodibenzo-p-dioxin promotes injury-induced vascular neointima formation in mice.
    Guo S; Zhang R; Liu Q; Wan Q; Wang Y; Yu Y; Liu G; Shen Y; Yu Y; Zhang J
    FASEB J; 2019 Sep; 33(9):10207-10217. PubMed ID: 31216422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PPARγ attenuates intimal hyperplasia by inhibiting TLR4-mediated inflammation in vascular smooth muscle cells.
    Zhang LL; Gao CY; Fang CQ; Wang YJ; Gao D; Yao GE; Xiang J; Wang JZ; Li JC
    Cardiovasc Res; 2011 Dec; 92(3):484-93. PubMed ID: 21880694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IQGAP1 links PDGF receptor-β signal to focal adhesions involved in vascular smooth muscle cell migration: role in neointimal formation after vascular injury.
    Kohno T; Urao N; Ashino T; Sudhahar V; Inomata H; Yamaoka-Tojo M; McKinney RD; Fukai T; Ushio-Fukai M
    Am J Physiol Cell Physiol; 2013 Sep; 305(6):C591-600. PubMed ID: 23657573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. C1q/TNF-related protein 1 prevents neointimal formation after arterial injury.
    Kanemura N; Shibata R; Ohashi K; Ogawa H; Hiramatsu-Ito M; Enomoto T; Yuasa D; Ito M; Hayakawa S; Otaka N; Murohara T; Ouchi N
    Atherosclerosis; 2017 Feb; 257():138-145. PubMed ID: 28131048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nitric oxide prevents aortic neointimal hyperplasia by controlling macrophage polarization.
    Lavin B; Gómez M; Pello OM; Castejon B; Piedras MJ; Saura M; Zaragoza C
    Arterioscler Thromb Vasc Biol; 2014 Aug; 34(8):1739-46. PubMed ID: 24925976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted disruption of the prostaglandin E2 E-prostanoid 2 receptor exacerbates vascular neointimal formation in mice.
    Zhu S; Xue R; Zhao P; Fan FL; Kong X; Zheng S; Han Q; Zhu Y; Wang N; Yang J; Guan Y
    Arterioscler Thromb Vasc Biol; 2011 Aug; 31(8):1739-47. PubMed ID: 21636806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Syndecan-4 deficiency limits neointimal formation after vascular injury by regulating vascular smooth muscle cell proliferation and vascular progenitor cell mobilization.
    Ikesue M; Matsui Y; Ohta D; Danzaki K; Ito K; Kanayama M; Kurotaki D; Morimoto J; Kojima T; Tsutsui H; Uede T
    Arterioscler Thromb Vasc Biol; 2011 May; 31(5):1066-74. PubMed ID: 21330609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adipose-derived protein omentin prevents neointimal formation after arterial injury.
    Uemura Y; Shibata R; Kanemura N; Ohashi K; Kambara T; Hiramatsu-Ito M; Enomoto T; Yuasa D; Joki Y; Matsuo K; Ito M; Hayakawa S; Ogawa H; Murohara T; Ouchi N
    FASEB J; 2015 Jan; 29(1):141-51. PubMed ID: 25300621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Activation Function-1 of Estrogen Receptor Alpha Prevents Arterial Neointima Development Through a Direct Effect on Smooth Muscle Cells.
    Smirnova NF; Fontaine C; Buscato M; Lupieri A; Vinel A; Valera MC; Guillaume M; Malet N; Foidart JM; Raymond-Letron I; Lenfant F; Gourdy P; Katzenellenbogen BS; Katzenellenbogen JA; Laffargue M; Arnal JF
    Circ Res; 2015 Oct; 117(9):770-8. PubMed ID: 26316608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.